FOR AUTHORS
Search
Search Results
Found 22 items.
-
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients
Published: 17 March 20142364PDF: 1293 -
-
On the history of biological drugs: the true discovery of the IL-1 receptor antagonist
Published: 19 July 2012679PDF (Italiano): 375 -
Possible relationship between certolizumab pegol and arrhythmias: report of two cases
Published: 9 September 20161412PDF: 898 -
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
Published: 31 December 20161532PDF: 835 -
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report
Published: 19 March 2012798PDF: 1452 -
A short history of anti-rheumatic therapy - VII. Biological agents
Published: 9 November 20111252PDF: 1166 -
The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects
Published: 11 April 2005811PDF: 1833 -
Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy
Published:1110PDF: 851 -
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
Published:1961PDF: 1022 -
-
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis
Published: 7 February 20228382PDF: 1690 -
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report
Published:1093PDF: 832 -
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Published: 19 November 20201356PDF: 916 -
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
Published: 8 May 20231016PDF: 569 -
-
Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study
Published: 28 January 20201041PDF: 647 -
1 - 22 of 22 items